https://clinicaltrials.gov/ct2/show/NCT03575195?recrs=abdef&type=Intr&cond=Parkinson+Disease&phase=0124&lupd_s=07%2F31%2F2020&lupd_d=14&sort=nwst
STUDY TITLE:
Microbiota Intervention to Change the Response of Parkinson’s Disease
DESCRIPTION:
Condition: Parkinson Disease
Interventions: Drug: Rifaximin; Other: Placebo
Sponsors: University of California, San Francisco; Nova Southeastern University; Gateway Institute for Brain Research
Recruiting
CLINICALTRIALS.GOV IDENTIFIER:
NCT03575195
FIRST POSTED:
Mon, 02 Jul 2018 12:00:00 EDT
LAST UPDATE POSTED:
08/14/20 07:39AM
STUDY LINK / URL:
https://clinicaltrials.gov/ct2/show/NCT03575195?recrs=abdef&type=Intr&cond=Parkinson+Disease&phase=0124&lupd_s=07%2F31%2F2020&lupd_d=14&sort=nwst